Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for STAR-CRISPR with the United States Patent and Trademark Office. The USPTO has given the STAR-CRISPR trademark a serial number of 79426106. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 5, 2025. This trademark is owned by Celyntra Therapeutics SA. The STAR-CRISPR trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Structural and functional analysis of genomes; research and development in the field of microorganisms and cells; research in the field of gene editing technology; genetic research; gene therapy research; scientific research in the field of genetics and genetic engineering; research in the field of gene therapy; research in the field of genetic diseases; scientific research relating to genetics; biotechnology research; biotechnology testing; preparation of reports in the biotechnology field; research and testing of cell-based products, in particular therapeutic products; research, optimization and testing of cell production processes; laboratory research in the field of biotechnology using genetically modified ips (induced pluripotent stem) cells or differentiated cells derived therefrom; scientific research, design and development of scientific cell culture, cell therapy or gene edited cell therapy; scientific research, design and development of cell culture, cell therapy or gene edit...
Reagents for research purposes; reagents used in science; reagents for scientific purposes; reagents for medical research; laboratory reagents for scientific use; chemical reagents for scientific purposes; reagents for scientific or medical research use; chemical reagents for use in genetic research; chemical reagents for use in biotechnology, other than for medical or veterinary use; specialized reagents for genome editing for scientific, research, and laboratory use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells and differentiated cells derived therefrom, for research or scientific purposes; cell cultures, cell culture systems and cryopreserved genetically modified ips cells for scientific and industrial research purposes; cell cultures, and cryopreserved cells ips cells other than for medical or veterinary use; compositions and materials for scientific use, including cell culture agents for use in the biotechnology industry and cell material...
Custom manufacturing of iPS derived cells, and iPS derived cell therapy and manufacturing processes for others, including manufacturing in GMP-based facilities; custom manufacture of therapeutic cells, medicines, cell therapies and gene edited cell therapies for others, including manufacturing in GMP-based facilities; custom manufacture of cellular therapies, including manufacturing in GMP-based facilities; manufacturing of cell lines (modified cells with specific genetic edits) for use in generating other cells.
Medical diagnostic reagents; clinical medical reagents; clinical diagnostic reagents; reagents for use in medical genetic testing; cells for medical use; genetic identity tests comprised of reagents for medical purposes; specialized reagents for genome editing for medical and medical clinical use; modified cells, in particular genetically modified ips (induced pluripotent stem) cells or differentiated cells derived therefrom, for medical or veterinary use; cell cultures and cell culture systems, and cryopreserved pluripotent stem cells for medical or veterinary use; genetically modified ips (induced pluripotent stem) cells for use in generating other cells for therapeutic purposes; cell cultures and cell culture systems, and cryopreserved genetically modified pluripotent stem cells for sub cultivation of cells, for medical or veterinary use.
